InvestorsHub Logo

rocioyogi

07/15/18 1:38 PM

#294610 RE: elichen #294606

Actually agree in that we don’t get as high a price on the buy out but much sooner to $2 to $3 a share although if all goes as planned and everything is approved you could be looking at 10 to 20 is share in 2 yrs; so where do you put it at 2-4-6 pps before this gets hot and heavy in a year from now

The ELTP King

07/16/18 12:07 AM

#294619 RE: elichen #294606

Which is exactly why we will be bought soon after SequestOx approval.

We have 8 additional two-bead ADT products ready to go into trials but have no money.

We also have an entire line of the new unique ADT products.

100+ million dollars to get all these going at once. Will take Elite years of waiting before they have enough cash.

Big pharma can get all these products through the trials at the same time and on the market much earlier than Elite.

Would also be in the best interests of the public, since ELTP’s ADTs would be available probably much sooner.